Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2018, Article ID 7202548, 15 pages
https://doi.org/10.1155/2018/7202548
Research Article

Propolin C Inhibited Migration and Invasion via Suppression of EGFR-Mediated Epithelial-to-Mesenchymal Transition in Human Lung Cancer Cells

1Division of Hematology and Oncology, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan City, Taiwan
2Department of Nutritional Science, Fu Jen Catholic University, New Taipei City, Taiwan
3Graduate Institute of Natural Products, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan
4Center for Traditional Chinese Medicine, Chang Gung Memorial Hospital, Taoyuan City, Taiwan

Correspondence should be addressed to Yann-Lii Leu; wt.ude.ugc.liam@uelly and Meng-Shih Weng; wt.ude.ujf.liam@076870

Received 16 October 2017; Accepted 28 January 2018; Published 25 February 2018

Academic Editor: Marco F. L. Lemos

Copyright © 2018 Jih-Tung Pai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. S. Veiga, S. De Mendonca, P. B. Mendes et al., “Artepillin C and phenolic compounds responsible for antimicrobial and antioxidant activity of green propolis and Baccharis dracunculifolia DC,” Journal of Applied Microbiology, vol. 122, no. 4, pp. 911–920, 2017. View at Publisher · View at Google Scholar · View at Scopus
  2. A. P. Dantas, K. Salomao, H. S. Barbosa, and S. L. De Castro, “The effect of Bulgarian propolis against Trypanosoma cruzi and during its interaction with host cells,” Memórias do Instituto Oswaldo Cruz, vol. 101, no. 2, pp. 207–211, 2006. View at Publisher · View at Google Scholar
  3. F. Borrelli, P. Maffia, L. Pinto et al., “Phytochemical compounds involved in the anti-inflammatory effect of propolis extract,” Fitoterapia, vol. 73, supplement 1, pp. S53–S63, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. D. Sawicka, H. Car, M. H. Borawska, and J. Nikliski, “The anticancer activity of propolis,” Folia Histochemica et Cytobiologica, vol. 50, pp. 25–37, 2012. View at Publisher · View at Google Scholar
  5. V. Bankova, “Chemical diversity of propolis and the problem of standardization,” Journal of Ethnopharmacology, vol. 100, no. 1-2, pp. 114–117, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. V. Bankova, M. Popova, S. Bogdanov, and A. G. Sabatini, “Chemical composition of European propolis: expected and unexpected results,” Zeitschrift für Naturforschung C. A Journal of Biosciences, vol. 57, no. 5-6, pp. 530–533, 2002. View at Google Scholar · View at Scopus
  7. A. G. Hegazi, F. K. Abd El Hady, and F. A. Abd Allah, “Chemical Composition and Antimicrobial Activity of European Propolis,” Zeitschrift für Naturforschung C, vol. 55, no. 1-2, 2000. View at Publisher · View at Google Scholar
  8. M. Velikova, V. Bankova, M. C. Marcucci, I. Tsvetkova, and A. Kujumgiev, “Chemical composition and biological activity of propolis from Brazilian Meliponinae,” Zeitschrift für Naturforschung C, vol. 55, no. 9-10, pp. 785–789, 2000. View at Google Scholar · View at Scopus
  9. B. Trusheva, M. Popova, and V. Bankova, “Bioactive constituents of Brazilian red propolis,” Evidence-Based Complementary and Alternative Medicine, vol. 3, no. 2, pp. 249–254, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. C.-N. Chen, C.-L. Wu, H.-S. Shy, and J.-K. Lin, “Cytotoxic prenylflavanones from Taiwanese propolis,” Journal of Natural Products, vol. 66, no. 4, pp. 503–506, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Kumazawa, H. Goto, T. Hamasaka, S. Fukumoto, T. Fujimoto, and T. Nakayama, “A new prenylated flavonoid from propolis collected in Okinawa, Japan,” Bioscience, Biotechnology, and Biochemistry, vol. 68, no. 1, pp. 260–262, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Kumazawa, J. Nakamura, M. Murase, M. Miyagawa, M.-R. Ahn, and S. Fukumoto, “Plant origin of Okinawan propolis: Honeybee behavior observation and phytochemical analysis,” Naturwissenschaften, vol. 95, no. 8, pp. 781–786, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Popova, C.-N. Chen, P.-Y. Chen, C.-Y. Huang, and V. Bankova, “A validated spectrophotometric method for quantification of prenylated flavanones in pacific propolis from Taiwan,” Phytochemical Analysis, vol. 21, no. 2, pp. 186–191, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. C.-N. Chen, C.-L. Wu, and J.-K. Lin, “Propolin C from propolis induces apoptosis through activating caspases, Bid and cytochrome c release in human melanoma cells,” Biochemical Pharmacology, vol. 67, no. 1, pp. 53–66, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. C.-N. Chen, C.-L. Wu, and J.-K. Lin, “Apoptosis of human melanoma cells induced by the novel compounds propolin A and propolin B from Taiwenese propolis,” Cancer Letters, vol. 245, no. 1-2, pp. 218–231, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. M.-S. Weng, C.-H. Liao, C.-N. Chen, C.-L. Wu, and J.-K. Lin, “Propolin H from Taiwanese propolis induces G1 arrest in human lung carcinoma cells,” Journal of Agricultural and Food Chemistry, vol. 55, no. 13, pp. 5289–5298, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. W.-J. Huang, C.-H. Huang, C.-L. Wu et al., “Propolin G, a prenylflavanone, isolated from Taiwanese propolis, induces caspase-dependent apoptosis in brain cancer cells,” Journal of Agricultural and Food Chemistry, vol. 55, no. 18, pp. 7366–7376, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Chen, M. Weng, C. Wu, and J. Lin, “Comparison of radical scavenging activity, cytotoxic effects and apoptosis induction in human melanoma cells by taiwanese propolis from different sources,” Evidence-Based Complementary and Alternative Medicine, vol. 1, no. 2, pp. 175–185, 2004. View at Publisher · View at Google Scholar
  19. M. R. Davidson, A. F. Gazdar, and B. E. Clarke, “The pivotal role of pathology in the management of lung cancer,” Journal of Thoracic Disease, vol. 5, pp. S463–S478, 2013. View at Google Scholar
  20. F. R. Hirsch, M. Varella-Garcia, P. A. Bunn Jr. et al., “Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis,” Journal of Clinical Oncology, vol. 21, no. 20, pp. 3798–3807, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Kosaka, Y. Yatabe, H. Endoh, H. Kuwano, T. Takahashi, and T. Mitsudomi, “Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications,” Cancer Research, vol. 64, no. 24, pp. 8919–8923, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. N. Normanno, A. de Luca, C. Bianco et al., “Epidermal growth factor receptor (EGFR) signaling in cancer,” Gene, vol. 366, no. 1, pp. 2–16, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Greenburg and E. D. Hay, “Epithelia suspended in collagen gels can lose polarity and express characteristics of migrating mesenchymal cells,” The Journal of Cell Biology, vol. 95, no. 1, pp. 333–339, 1982. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Guarino, B. Rubino, and G. Ballabio, “The role of epithelial-mesenchymal transition in cancer pathology,” Pathology, vol. 39, no. 3, pp. 305–318, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. J. P. Thiery, H. Acloque, R. Y. J. Huang, and M. A. Nieto, “Epithelial-mesenchymal transitions in development and disease,” Cell, vol. 139, no. 5, pp. 871–890, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. C. L. Chaffer and R. A. Weinberg, “A perspective on cancer cell metastasis,” Science, vol. 331, no. 6024, pp. 1559–1564, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. Shintani, A. Okimura, K. Sato et al., “Epithelial to mesenchymal transition is a determinant of sensitivity to chemoradiotherapy in non-small cell lung cancer,” The Annals of Thoracic Surgery, vol. 92, no. 5, pp. 1794–1804, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. P. Bendinelli, P. Maroni, E. Matteucci, and M. A. Desiderio, “HGF and TGFβ1 differently influenced Wwox regulatory function on Twist program for mesenchymal-epithelial transition in bone metastatic versus parental breast carcinoma cells,” Molecular Cancer, vol. 14, no. 1, article no. 112, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Kim, J. Kong, H. Chang, H. Kim, and A. Kim, “EGF induces epithelial-mesenchymal transition through phospho-Smad2/3-Snail signaling pathway in breast cancer cells,” Oncotarget , vol. 7, no. 51, pp. 85021–85032, 2016. View at Publisher · View at Google Scholar · View at Scopus
  30. F. A. Bhat, G. Sharmila, S. Balakrishnan et al., “Quercetin reverses EGF-induced epithelial to mesenchymal transition and invasiveness in prostate cancer (PC-3) cell line via EGFR/PI3K/Akt pathway,” The Journal of Nutritional Biochemistry, vol. 25, no. 11, pp. 1132–1139, 2014. View at Publisher · View at Google Scholar
  31. S.-Y. Yu, C.-H. Liao, M.-H. Chien, T.-Y. Tsai, J.-K. Lin, and M.-S. Weng, “Induction of p21Waf1/Cip1 by garcinol via downregulation of p38-MAPK signaling in p53-independent H1299 lung cancer,” Journal of Agricultural and Food Chemistry, vol. 62, no. 9, pp. 2085–2095, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. S.-J. Kao, J.-L. Su, C.-K. Chen et al., “Osthole inhibits the invasive ability of human lung adenocarcinoma cells via suppression of NF-κB-mediated matrix metalloproteinase-9 expression,” Toxicology and Applied Pharmacology, vol. 261, no. 1, pp. 105–115, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. R. Kotecha, A. Takami, and J. L. Espinoza, “Dietary phytochemicals and cancer chemoprevention: a review of the clinical evidence,” Oncotarget , vol. 7, no. 32, pp. 52517–52529, 2016. View at Publisher · View at Google Scholar · View at Scopus
  34. D. Jie, Z. Zhongmin, L. Guoqing et al., “Positive expression of LSD1 and negative expression of E-cadherin correlate with metastasis and poor prognosis of colon cancer,” Digestive Diseases and Sciences, vol. 58, no. 6, pp. 1581–1589, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. N. P. Tobin, A. H. Sims, K. L. Lundgren, S. Lehn, and G. Landberg, “Cyclin D1, Id1 and EMT in breast cancer,” BMC Cancer, vol. 11, article no. 417, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Sato, D. S. Shames, and Y. Hasegawa, “Emerging evidence of epithelial-to-mesenchymal transition in lung carcinogenesis,” Respirology, vol. 17, no. 7, pp. 1048–1059, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. Y. Nie, W. Gao, N. Li et al., “Relationship between EGFR gene mutation and local metastasis of resectable lung adenocarcinoma,” World Journal of Surgical Oncology, vol. 15, no. 1, article no. 55, 2017. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Blanco-Prieto, L. Vazquez-Iglesias, M. Rodriguez-Girondo et al., “Serum calprotectin, CD26 and EGF to establish a panel for the diagnosis of lung cancer,” PLoS ONE, vol. 10, no. 5, Article ID e0127318, 2015. View at Publisher · View at Google Scholar · View at Scopus
  39. J.-H. Zuo, W. Zhu, M.-Y. Li et al., “Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT-like phenotype change and MMP-9-mediated degradation of E-cadherin,” Journal of Cellular Biochemistry, vol. 112, no. 9, pp. 2508–2517, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. N. Liu, Y. Li, S. Su, N. Wang, H. Wang, and J. Li, “Inhibition of cell migration by ouabain in the A549 human lung cancer cell line,” Oncology Letters, vol. 6, no. 2, pp. 475–479, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. T. Tanahashi, S. Osada, A. Yamada et al., “Extracellular signal-regulated kinase and Akt activation play a critical role in the process of hepatocyte growth factor-induced epithelial-mesenchymal transition,” International Journal of Oncology, vol. 42, no. 2, pp. 556–564, 2013. View at Publisher · View at Google Scholar · View at Scopus
  42. Y.-S. Hsieh, C.-H. Liao, W.-S. Chen, J.-T. Pai, and M.-S. Weng, “Shikonin Inhibited Migration and Invasion of Human Lung Cancer Cells via Suppression of c-Met-Mediated Epithelial-to-Mesenchymal Transition,” Journal of Cellular Biochemistry, vol. 118, no. 12, pp. 4639–4651, 2017. View at Publisher · View at Google Scholar · View at Scopus
  43. H. T. Feng, W. W. Zhao, J. J. Lu, Y. T. Wang, and X. P. Chen, “Hypaconitine inhibits TGF-beta1-induced epithelial-mesenchymal transition and suppresses adhesion, migration, and invasion of lung cancer A549 cells,” Chinese Journal of Natural Medicines, vol. 15, no. 6, pp. 427–435, 2017. View at Google Scholar
  44. L. Qi, W. Song, L. Li et al., “FGF4 induces epithelial-mesenchymal transition by inducing store-operated calcium entry in lung adenocarcinoma,” Oncotarget , vol. 7, no. 45, pp. 74015–74030, 2016. View at Publisher · View at Google Scholar · View at Scopus